Cancer Genetics, a global partner for biopharma companies

Posted on: Thursday, May 28th, 2015

Panna Sharma, CEO of Cancer Genetics, Inc. speaks about Cancer genetics, a global partner for biopharma companies

Globally cancer is increasing significantly and with that increase comes more complexity to understand and diagnose cancers. In countries like India or China, they expect a 5 fold increase of newly diagnosed cancers, and also significant increase of cost associated with care.

As Biotech & Pharma companies expand their clinical trials globally, there is a significant need for them to have the same global standards, the same quality results and same the data across the globe, and across multiple sites.

Biotech & Pharma companies are facing the duel challenge of decreasing the cost of their clinical trials while they need to improve the speed at which they are able to get to approval.  With facilities in India & China, Cancer Genetics can ensure that all labs maintain the same level of results, the same level quality, and follow the same SOPs.

In both these countries, it is not only essential that we serve the biopharma companies, but equally essential that the patients in these countries get access to the same quality genomic tests and same standards in data that our test provide.

Cancer Genetics is expanding its footprint. Cancer Genetics is empowering the personalization of cancer treatment globally.

Filed Under:

> Additional Articles
> Join Our Mailing List

Additional Videos»

  • Cancer Genetics offers the FDA-approved DAKO PD-L1 IHC 22C3 pharmDx companion diagnostic test for KEYTRUDA®

    The FDA approved PD-L1 (IHC) 22C3 pharmDx companion diagnostic test for  KEYTRUDA® (pembrolizumab)​ is now available at CGI to assess PD-L1 expression in Non-Small Cell Lung Cancer

  • Cancer Genetics is a center of excellence for oncology-focused clinical trials.

    Narasimha Marella, Ph.D., Corporate Development Manager speaks about how Cancer Genetics can help biopharma companies overcome oncology-focused clinical trial challenges. The current challenge that is faced by biotech and biopharmas that are involved in oncology drug development is their ability to accurately stratify and randomize patients for their clinical trials based on biomarkers. Despite the […]

  • Cancer Genetics offers an integrated solution for clinical trials.

    Kristen Hopp, PMP, Senior Clinical Trial Project Associate speaks about Cancer Genetics integrated clinical trial services. In hematological malignancies one of the challenges is the diversity of subtypes.  For these trials, genomic insights have become critically important.  Our innovative research and our clinical expertise in these cancers makes CGI an ideal partner for these clinical […]

  • Cancer Genetics offers an integrated solution for Clinical Trials.

    Nathan Campbell, Director of Clinical Services speaks about Cancer Genetics’ Biorepository capability and how having access to samples genomic data is important. As a clinical trial progresses and a more diverse patient population is recruited, variations in a drug’s efficacy and safety can start to arise. Unexpected adverse events can potentially kill a drug at […]

See All Videos Back to Top